Ovagen is studied in tissue regeneration and repair research, including cell and animal models. For the sequence-related peptide studied under code T-35, an effect on the matrix metalloproteinase MMP-14 in kidney-cell culture was described. A mechanism of action in ovarian tissue is not described anywhere in the literature.
The accessible literature discusses this peptide in relation to liver and gastrointestinal cell function, not ovarian function. No robust data supporting a reproductive-medicine benefit were found in this research.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
Specific study references will be added for this product. For current literature, independent research (e.g. via PubMed) is recommended.
We reply personally – via email or Telegram.